Biochemical and neurosurgical analyses of circulating neuroglobin and somatic mutations in IDH1 gene in patients with traumatic brain injury

References

• Baez E, Echeverria V, Cabezas R, et al. Protection by neuroglobin expression in brain pathologies. Front Neurol. 2016;7:146.
   Google Scholar
• Gotting M, Nikinmaa M. More than hemoglobin – the unexpected diversity of globins in vertebrate red blood cells. Physiol Rep. 2015;3:e12284.
   Google Scholar
• Lee VY, McClintock DS, Santore MT, et al. Hypoxia sensitizes cells to nitric oxide-induced apoptosis. J Biol Chem. 2002;277:16067–16074.
   Google Scholar
• Hankeln T, Ebner B, Fuchs C, et al. Neuroglobin and cytoglobin in search of their role in the vertebrate globin family. J InorgBiochem. 2005;99. 110–119.
   Google Scholar
• Fuchs C, Burmester T, Hankeln T. The amphibian globin gene repertoire as revealed by the Xenopus genome. Cytogenet Genome Res. 2006;112:296–306.
   Google Scholar
• De Marinis E, Fiocchetti M, Acconcia F, et al. Neuroglobin upregulation induced by 17β-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells. Cell Death Dis. 2013;4:e508.
   Google Scholar
• Wystub S, Laufs T, Schmidt M, et al. Localization of neuroglobin protein in the mouse brain. Neurosci Lett. 2003;346:114–116.
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807–1812.
   PubMed Web of Science ®Google Scholar
• Zhao S, Yu Z, Zhao G, et al. Neuroglobin-overexpression reduces traumatic brain lesion size in mice. BMC Neurosci. 2012;13:67.
   PubMed Web of Science ®Google Scholar
• Grassian AR, Parker SJ, Davidson SM, et al. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res. 2014;74:3317–3331.
   PubMed Web of Science ®Google Scholar
• Cuyàs E, Fernández-Arroyo S, Corominas-Faja B, et al. Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype. Oncotarget. 2015;6(14):12279–12296.
   Google Scholar
• Gilpin DA, Nelson PG. Revised trauma score: a triage tool in the accident and emergency department. Injury. 1991;22(1):35–37.
   Google Scholar
• Scranton J, Fogel ML, Erdman WJ 2nd. Evaluation of functional levels of patients during and following rehabilitation. Arch Phys Med Rehabil. 1970;51:1–21.
   PubMedGoogle Scholar
• Abuhamdah S, Saleem TH, Elsadek BE, et al. Circulating ubiquitin carboxyl terminal hydrolase L1 and neuroglobin levels in traumatic spinal cord injuries: relation to severity and outcomes. Int J Gen Med. 2022;15:5795–5805.
   PubMed Web of Science ®Google Scholar
• Meyer J, Pusch S, Balss J, et al. PCR- and restriction endonuclease-based detection of IDH1 mutations. Brain Pathol. 2010;20(2):298–300.
   Google Scholar
• Elsayed GM, Nassar HR, Zaher A, et al. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients. J Egypt Natl Canc Inst. 2014;26(1):43–49.
   Google Scholar
• Mohamed Yusoff AA, Zulfakhar FN, Sul’ain MD, et al. Association of the IDH1 C.395G>A (R132H) mutation with histological type in malay brain tumors. Asian Pac J Cancer Prev. 2016;17(12):5195–5201.
   Google Scholar
• Hardy GH. Mendelian proportions in a mixed population. Science. 1908;28:49–50.
   PubMedGoogle Scholar
• Stark AE. A clarification of the Hardy-Weinberg law. Genetics. 2006;174:1695–1697.
   Web of Science ®Google Scholar
• Bowman K, Matney C, Berwick DM. Improving traumatic brain injury care and research: a report from the national academies of sciences, engineering, and medicine. JAMA. 2022;327(5):419–420.
   Google Scholar
• Sharma R, Laskowitz DT. Biomarkers in traumatic brain injury. Curr Neurol Neurosci Rep. 2012;12:560–569.
   PubMed Web of Science ®Google Scholar
• Leitgeb J, Mauritz W, Brazinova A, et al. Effects of gender on outcomes after traumatic brain injury. J Trauma. 2011;71(6):1620–1626.
   PubMed Web of Science ®Google Scholar
• Egea-Guerrero JJ, Murillo-Cabezas F, Gordillo-Escobar E, et al. S100B protein may detect brain death development after severe traumatic brain injury. J Neurotrauma. 2013;30(20):1762–1769.
   PubMed Web of Science ®Google Scholar
• Chen H, Cao H-L, Chen S-W, et al. Neuroglobin and Nogo-a as biomarkers for the severity and prognosis of traumatic brain injury. Biomarkers. 2015;20(6–7):495–501.
   PubMed Web of Science ®Google Scholar
• Ding C, Kang D, Chen P, et al. Early stage neuroglobin level as a predictor of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Brain Behav. 2020;10(3):e01547.
   Google Scholar
• Shang A, Zhou D, Wang L, et al. Increased neuroglobin levels in the cerebral cortex and serum after ischemia–reperfusion insults. Brain Res. 2006;1078(1):219–226.
   PubMedGoogle Scholar
• Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J Head Trauma Rehabil. 2006;21(4):315–333
   Google Scholar
• Bleeker FE, Atai NA, Lamba S, et al. The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol. 2010;119(4):487–494.
   PubMed Web of Science ®Google Scholar
• Huang J, Yu J, Tu L, et al. Isocitrate dehydrogenase mutations in glioma: from basic discovery to therapeutics development. Front Oncol. 2019;9:506.
   PubMed Web of Science ®Google Scholar
• Alzial G, Renoult O, Paris F, et al. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene. 2022;41:613–621.
   Google Scholar
• Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012;483:479–483.
   PubMed Web of Science ®Google Scholar